カテゴリー： QYResearch, 世界

世界の低酸素誘導因子1アルファ阻害剤市場

QYResearchが発行した調査報告書（DATA909X09523）
◆英語タイトル：Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Professional Survey Report 2019
◆商品コード：DATA909X09523
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月20日（※2024年版があります。お問い合わせください）
◆ページ数：114
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
※本調査レポートは、低酸素誘導因子1アルファ阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BC-001、CASI-2ME2、CRLX-101、その他に、用途別には、固形腫瘍、急性骨髄性白血病、大腸癌、その他にセグメント区分し、低酸素誘導因子1アルファ阻害剤の世界市場を分析しました。


・エグゼクティブ・サマリー
・低酸素誘導因子1アルファ阻害剤の世界市場概要
・低酸素誘導因子1アルファ阻害剤の製造コスト構成分析
・低酸素誘導因子1アルファ阻害剤の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・低酸素誘導因子1アルファ阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・低酸素誘導因子1アルファ阻害剤のセグメント分析（種類別）
（BC-001、CASI-2ME2、CRLX-101、その他）
・低酸素誘導因子1アルファ阻害剤のセグメント分析（用途別）
（固形腫瘍、急性骨髄性白血病、大腸癌、その他）
・低酸素誘導因子1アルファ阻害剤の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Aileron Therapeutics, Inc.、CASI Pharmaceuticals Inc.、Cerulean Pharma, Inc.、F. Hoffmann-La Roche Ltd.、InterMed Discovery GmbH、OncoImmune, Inc.、Peloton Therapeutics, Inc.、RXi Pharmaceuticals Corporation、Sorrento Therapeutics, Inc.、Transcriptogen Ltd、Vascular Biogenics Ltd.、）
・低酸素誘導因子1アルファ阻害剤の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Hypoxia Inducible Factor 1 Alpha Inhibitor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Hypoxia Inducible Factor 1 Alpha Inhibitor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypoxia Inducible Factor 1 Alpha Inhibitor market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hypoxia Inducible Factor 1 Alpha Inhibitor in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hypoxia Inducible Factor 1 Alpha Inhibitor manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Aileron Therapeutics, Inc.
CASI Pharmaceuticals Inc.
Cerulean Pharma, Inc.
F. Hoffmann-La Roche Ltd.
InterMed Discovery GmbH
OncoImmune, Inc.
Peloton Therapeutics, Inc.
RXi Pharmaceuticals Corporation
Sorrento Therapeutics, Inc.
Transcriptogen Ltd
Vascular Biogenics Ltd.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
BC-001
CASI-2ME2
CRLX-101
Others

Segment by Application
Solid Tumor
Acute Myelocytic Leukemia
Colorectal Cancer
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Hypoxia Inducible Factor 1 Alpha Inhibitor
1.1 Definition of Hypoxia Inducible Factor 1 Alpha Inhibitor
1.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Segment by Type
1.2.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate Comparison by Types (2014-2025)
1.2.2 BC-001
1.2.3 CASI-2ME2
1.2.4 CRLX-101
1.2.5 Others
1.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Segment by Applications
1.3.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Comparison by Applications (2014-2025)
1.3.2 Solid Tumor
1.3.3 Acute Myelocytic Leukemia
1.3.4 Colorectal Cancer
1.3.5 Others
1.4 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Overall Market
1.4.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (2014-2025)
1.4.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production (2014-2025)
1.4.3 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)
1.4.4 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)
1.4.5 China Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)
1.4.6 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)
1.4.7 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)
1.4.8 India Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor
2.3 Manufacturing Process Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor
2.4 Industry Chain Structure of Hypoxia Inducible Factor 1 Alpha Inhibitor

3 Development and Manufacturing Plants Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor
3.1 Capacity and Commercial Production Date
3.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Hypoxia Inducible Factor 1 Alpha Inhibitor
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Production and Capacity Analysis
4.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Analysis
4.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Price Analysis
4.4 Market Concentration Degree

5 Hypoxia Inducible Factor 1 Alpha Inhibitor Regional Market Analysis
5.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Production by Regions
5.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production by Regions
5.1.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Regions
5.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption by Regions
5.3 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
5.3.1 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Production
5.3.2 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export
5.4 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
5.4.1 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Production
5.4.2 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export
5.5 China Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
5.5.1 China Hypoxia Inducible Factor 1 Alpha Inhibitor Production
5.5.2 China Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export
5.6 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
5.6.1 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Production
5.6.2 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export
5.7 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
5.7.1 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Production
5.7.2 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export
5.8 India Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
5.8.1 India Hypoxia Inducible Factor 1 Alpha Inhibitor Production
5.8.2 India Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export

6 Hypoxia Inducible Factor 1 Alpha Inhibitor Segment Market Analysis (by Type)
6.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production by Type
6.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Type
6.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Type

7 Hypoxia Inducible Factor 1 Alpha Inhibitor Segment Market Analysis (by Application)
7.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption by Application
7.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Market Share by Application (2014-2019)

8 Hypoxia Inducible Factor 1 Alpha Inhibitor Major Manufacturers Analysis
8.1 Aileron Therapeutics, Inc.
8.1.1 Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.1.2 Aileron Therapeutics, Inc. Product Introduction, Application and Specification
8.1.3 Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 CASI Pharmaceuticals Inc.
8.2.1 CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.2.2 CASI Pharmaceuticals Inc. Product Introduction, Application and Specification
8.2.3 CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Cerulean Pharma, Inc.
8.3.1 Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.3.2 Cerulean Pharma, Inc. Product Introduction, Application and Specification
8.3.3 Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.4.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
8.4.3 F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 InterMed Discovery GmbH
8.5.1 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.5.2 InterMed Discovery GmbH Product Introduction, Application and Specification
8.5.3 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 OncoImmune, Inc.
8.6.1 OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.6.2 OncoImmune, Inc. Product Introduction, Application and Specification
8.6.3 OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Peloton Therapeutics, Inc.
8.7.1 Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.7.2 Peloton Therapeutics, Inc. Product Introduction, Application and Specification
8.7.3 Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 RXi Pharmaceuticals Corporation
8.8.1 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.8.2 RXi Pharmaceuticals Corporation Product Introduction, Application and Specification
8.8.3 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Sorrento Therapeutics, Inc.
8.9.1 Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.9.2 Sorrento Therapeutics, Inc. Product Introduction, Application and Specification
8.9.3 Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Transcriptogen Ltd
8.10.1 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
8.10.2 Transcriptogen Ltd Product Introduction, Application and Specification
8.10.3 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Vascular Biogenics Ltd.

9 Development Trend of Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor Market
9.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Trend Analysis
9.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Volume and Value) Forecast 2019-2025
9.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Regional Market Trend
9.2.1 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
9.2.2 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
9.2.3 China Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
9.2.4 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
9.2.5 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
9.2.6 India Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
9.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Market Trend (Product Type)
9.4 Hypoxia Inducible Factor 1 Alpha Inhibitor Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Hypoxia Inducible Factor 1 Alpha Inhibitor
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share by Types in 2018
Figure BC-001 Product Picture
Figure CASI-2ME2 Product Picture
Figure CRLX-101 Product Picture
Figure Others Product Picture
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Market Share by Applications in 2018
Figure Solid Tumor
Figure Acute Myelocytic Leukemia
Figure Colorectal Cancer
Figure Others
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (Million USD) (2014-2025)
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs) (2014-2025)
Figure North America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Million USD) (2014-2025)
Figure Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Million USD) (2014-2025)
Figure China Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Million USD) (2014-2025)
Figure Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Million USD) (2014-2025)
Figure Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Million USD) (2014-2025)
Figure India Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Million USD) (2014-2025)
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor in 2018
Figure Manufacturing Process Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor
Figure Industry Chain Structure of Hypoxia Inducible Factor 1 Alpha Inhibitor
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Plants Distribution
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs) of Major Manufacturers (2014-2019)
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share of Major Manufacturers (2014-2019)
Figure Hypoxia Inducible Factor 1 Alpha Inhibitor Production Share by Manufacturers in 2018
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share of Major Manufacturers (2014-2019)
Figure Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Share by Manufacturers in 2018
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production by Regions 2014-2019 (K Pcs)
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share by Regions 2014-2019
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share by Regions in 2018
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Regions 2014-2019 (Million USD)
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Regions 2014-2019
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Regions in 2018
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption by Regions 2014-2019 (K Pcs)
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Market Share by Regions 2014-2019
Figure North America Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table North America Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Consumption Import and Export (K Pcs)
Figure Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Consumption Import and Export (K Pcs)
Figure China Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure China Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table China Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Consumption Import and Export (K Pcs)
Figure Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Consumption Import and Export (K Pcs)
Figure India Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure India Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table India Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Application (2014-2019)
Figure Global Value (Consumption) Hypoxia Inducible Factor 1 Alpha Inhibitor Market Share by Application (2014-2019)
Table Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Table Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Product Introduction, Application and Specification
Table Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate (2014-2019)
Table Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Production Market Share (2014-2019)
Figure Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share (2014-2019)
Table Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Main Business and Markets Served
Table Vascular Biogenics Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Hypoxia Inducible Factor 1 Alpha Inhibitor by Type (2019-2025)
Table Global Consumption (K Pcs) of Hypoxia Inducible Factor 1 Alpha Inhibitor by Application (2019-2025)
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Distributors List
Table Hypoxia Inducible Factor 1 Alpha Inhibitor Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Aileron Therapeutics, Inc.、CASI Pharmaceuticals Inc.、Cerulean Pharma, Inc.、F. Hoffmann-La Roche Ltd.、InterMed Discovery GmbH、OncoImmune, Inc.、Peloton Therapeutics, Inc.、RXi Pharmaceuticals Corporation、Sorrento Therapeutics, Inc.、Transcriptogen Ltd、Vascular Biogenics Ltd.、

【免責事項】
https://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の低酸素誘導因子1アルファ阻害剤市場(Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のトランスグルタミナーゼ調製産業：成長傾向・競合分析
  • 世界のトグルボルト産業：成長傾向・競合分析
  • 世界の産業用発電産業：成長傾向・競合分析
  • 世界の風力インバータ市場
  • 世界のサーフ防水イヤホン市場
  • 世界の横紋筋肉腫薬市場
  • 世界の医薬品発酵槽市場
  • 世界のペットヘアケア市場
  • 世界のメラニン細胞タンパク質PMEL市場
  • 世界の医療用止血帯市場
  • 世界の硫酸ヒドロキシアンモニウム市場
  • 世界の固定及び可変真空コンデンサ市場
  • 世界の極低温用個人保護護具市場
  • 世界のビールディスペンサー市場
  • 世界のバッテリー管理IC市場